Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Non-Current Assets (2016 - 2025)

Mimedx (MDXG) has disclosed Non-Current Assets for 15 consecutive years, with $65.2 million as the latest value for Q4 2025.

  • Quarterly Non-Current Assets fell 9.51% to $65.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $270.6 million through Dec 2025, down 10.62% year-over-year, with the annual reading at $65.2 million for FY2025, 9.51% down from the prior year.
  • Non-Current Assets hit $65.2 million in Q4 2025 for Mimedx, roughly flat from $64.9 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $82.8 million in Q1 2024 to a low of $34.5 million in Q3 2023.
  • Historically, Non-Current Assets has averaged $53.1 million across 5 years, with a median of $40.2 million in 2021.
  • Biggest five-year swings in Non-Current Assets: soared 127.19% in 2024 and later fell 15.12% in 2025.
  • Year by year, Non-Current Assets stood at $39.4 million in 2021, then decreased by 5.52% to $37.2 million in 2022, then skyrocketed by 100.86% to $74.8 million in 2023, then dropped by 3.69% to $72.0 million in 2024, then dropped by 9.51% to $65.2 million in 2025.
  • Business Quant data shows Non-Current Assets for MDXG at $65.2 million in Q4 2025, $64.9 million in Q3 2025, and $70.2 million in Q2 2025.